1
|
Lonser RR, Glenn GM, Walther M, Chew EY,
Libutti SK, Linehan WM and Oldfield EH: von Hippel-Lindau disease.
Lancet. 361:2059–2067. 2003. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zou YU, Xu J and Zhang M: Long-term
follow-up and clinical course of a rare case of von Hippel-Lindau
disease: A case report and review of the literature. Oncol Lett.
11:3273–3278. 2016. View Article : Google Scholar : PubMed/NCBI
|
3
|
Bastos-Carvalho A and Damato B: Images in
clinical medicine. Retinal hemangioblastoma in von Hippel-Lindau
disease. N Engl J Med. 363:6632010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Schmidt-Erfurth UM, Kusserow C, Barbazetto
IA and Laqua H: Benefits and complications of photodynamic therapy
of papillary capillary hemangiomas. Ophthalmology. 109:1256–1266.
2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Gaudric A, Krivosic V, Duguid G, Massin P,
Giraud S and Richard S: Vitreoretinal surgery for severe retinal
capillary hemangiomas in von hippel-lindau disease. Ophthalmology.
118:142–149. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kase S and Ishida S: Retinal capillary
hemangioma in von Hippel-Lindau disease: Current concept, diagnosis
and managements. J Transl Med Epidemiol. 2:10102014.
|
7
|
McCabe CM, Flynn HW Jr, Shields CL,
Shields JA, Regillo CD, McDonald HR, Berrocal MH, Gass JD and
Mieler WF: Juxtapapillary capillary hemangiomas. Clinical features
and visual acuity outcomes. Ophthalmology. 107:2240–2248. 2000.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Magee MA, Kroll AJ, Lou PL and Ryan EA:
Retinal capillary hemangiomas and von Hippel-Lindau disease. Semin
Ophthalmol. 21:143–150. 2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Toy BC, Agrón E, Nigam D, Chew EY and Wong
WT: Longitudinal analysis of retinal hemangioblastomatosis and
visual function in ocular von Hippel-Lindau disease. Ophthalmology.
119:2622–2630. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ridley M, Green J and Johnson G: Retinal
angiomatosis: the ocular manifestations of von Hippel-Lindau
disease. Can J Ophthalmol. 21:276–283. 1986.PubMed/NCBI
|
11
|
Wittebol-Post D, Hes FJ and Lips CJ: The
eye in von Hippel-Lindau disease. Long-term follow-up of screening
and treatment: recommendations. J Intern Med. 243:555–561. 1998.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Maher ER, Yates JR, Harries R, Benjamin C,
Harris R, Moore AT and Ferguson-Smith MA: Clinical features and
natural history of von Hippel-Lindau disease. Q J Med.
77:1151–1163. 1990. View Article : Google Scholar : PubMed/NCBI
|
13
|
Singh AD, Nouri M, Shields CL, Shields JA
and Perez N: Treatment of retinal capillary hemangioma.
Ophthalmology. 109:1799–1806. 2002. View Article : Google Scholar : PubMed/NCBI
|
14
|
Saitta A, Nicolai M, Giovannini A and
Mariotti C: Juxtapapillary retinal capillary hemangioma: new
therapeutic strategies. Med Hypothesis Discov Innov Ophthalmol.
3:71–75. 2014.PubMed/NCBI
|
15
|
Toyokawa N, Kimura H and Kuroda S:
Juxtapapillary capillary hemangioma treated by intravitreal
injection of bevacizumab combined with posterior subtenon injection
of triamcinolone acetonide. Jpn J Ophthalmol. 54:168–170. 2010.
View Article : Google Scholar : PubMed/NCBI
|